The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2021 | The next steps in the treatment of NHL
Nirav N. Shah, MD, Medical College of Wisconsin, Brookfield, WI, discusses the next steps in the treatment of non-Hodgkin lymphoma (NHL), in particular commenting on the need for more precise treatments and optimization of therapy combinations. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.
Disclosures
Nirav N. Shah, MD, has participated in consultancy work and advisory board with Lily Pharmaceuticals.
